Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (91-100 of 311) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|December 9, 2023
Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse eventCédric Sztejkowski, Jean Sibilia, François Danion, et al.
Arthritis and Rheumatism|June 2, 2006
Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune featuresJulien Champey, Emmanuelle Corruble, Jacques-Eric Gottenberg, et al.
Seminars in Arthritis and Rheumatism|January 7, 2014
Gemcitabine-induced myopathyLionel Spielmann, Laurent Messer, Paul Moreau, et al.
Rheumatology (Oxford, England)|March 16, 2026
Acute myocarditis after switching between two adalimumab biosimilarsThomas Subervie, François Sauer, Jean-Jacques Von Hunolstein, et al.
Annals of the Rheumatic Diseases|December 23, 2006
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosusJérémie Sellam, Corinne Miceli-Richard, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|June 30, 2009
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Simon J Bowman, et al.
Stem Cell Research & Therapy|June 26, 2024
iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature reviewEltahir Abdelrazig Mohamed Ali, Rana Smaida, Morgane Meyer, et al.
RMD Open|August 16, 2019
Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritisAlexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, et al.
Joint Bone Spine|March 27, 2017
Inflammatory myopathies: A new landscapeAlain Meyer, Béatrice Lannes, Joëlle Goetz, et al.
Arthritis and Rheumatism|February 12, 2004
Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndromeJacques-Eric Gottenberg, Marc Busson, Pascale Loiseau, et al.
Pageof 32

Showing results (91-100 of 311) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|December 9, 2023
Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse eventCédric Sztejkowski, Jean Sibilia, François Danion, et al.
Arthritis and Rheumatism|June 2, 2006
Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune featuresJulien Champey, Emmanuelle Corruble, Jacques-Eric Gottenberg, et al.
Seminars in Arthritis and Rheumatism|January 7, 2014
Gemcitabine-induced myopathyLionel Spielmann, Laurent Messer, Paul Moreau, et al.
Rheumatology (Oxford, England)|March 16, 2026
Acute myocarditis after switching between two adalimumab biosimilarsThomas Subervie, François Sauer, Jean-Jacques Von Hunolstein, et al.
Annals of the Rheumatic Diseases|December 23, 2006
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosusJérémie Sellam, Corinne Miceli-Richard, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases|June 30, 2009
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Simon J Bowman, et al.
Stem Cell Research & Therapy|June 26, 2024
iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature reviewEltahir Abdelrazig Mohamed Ali, Rana Smaida, Morgane Meyer, et al.
RMD Open|August 16, 2019
Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritisAlexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, et al.
Joint Bone Spine|March 27, 2017
Inflammatory myopathies: A new landscapeAlain Meyer, Béatrice Lannes, Joëlle Goetz, et al.
Arthritis and Rheumatism|February 12, 2004
Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndromeJacques-Eric Gottenberg, Marc Busson, Pascale Loiseau, et al.
Pageof 32